Welcome to our dedicated page for Waters news (Ticker: WAT), a resource for investors and traders seeking the latest updates and insights on Waters stock.
Waters Corporation reports recurring developments across life sciences and diagnostics, including analytical instruments, informatics, service, and high-volume testing workflows. News for WAT commonly covers operating results and guidance, the Analytical Sciences Division, and the Biosciences and Diagnostic Solutions businesses added through the completed BD transaction.
Company updates also include product launches for liquid chromatography, UPLC and UHPLC workflows, MALS detection, rheometry, LC columns, and TA Instruments technologies. Diagnostic news includes FDA-related developments for the Onclarity HPV Self-Collection Kit and BD Onclarity HPV Assay, along with commercial, conference, and shareholder-related updates.
Waters Corporation (NYSE:WAT) announced the launch of its ACQUITY™ PREMIER Columns, featuring MaxPeak™ High Performance Surface (HPS) technology. These premium sub-2-micron columns significantly enhance data quality by reducing sample analyte loss due to adsorption. Designed for comprehensive use with UHPLC systems, these columns improve sample throughput and assay reproducibility, addressing a critical challenge in analytic laboratories. The product aims to bolster analytical confidence across various applications, including small molecules and biopharmaceuticals.
Waters Corporation (NYSE:WAT) will host a live webcast of its Q3 2020 financial results conference call on October 27 at 8:00 a.m. ET. Investors can access the call through Waters' website, with a replay available until November 3. Waters is a leader in specialty measurement technologies, focusing on chromatography, mass spectrometry, and thermal analysis across various sectors including life and materials sciences. The company operates in 35 countries with over 7,000 employees and has a significant global presence, featuring 15 manufacturing facilities.